First human tests begin for eli Lilly's new drug candidate
NCT ID NCT06709820
Summary
This early-stage study aims to check the safety and side effects of a new drug called LY4060874 in healthy people. Researchers will also measure how the body absorbs and processes the medication. The study involves 132 healthy volunteers and is the first step in testing this potential new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea, Inc.
Dallas, Texas, 75247, United States
-
Lilly Centre for Clinical Pharmacology
Singapore, 138623, Singapore
Conditions
Explore the condition pages connected to this study.